| | | 69672 | | 23.06.2025 | | NOBEL Pharma Schweiz AG | | | | | | | 22.06.2030 | | | | | | 120000. | | | | 12.02.30. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Ryaltris 25 μg / 600 μg | Nasenspray, Suspension | Nasal spray (Mometasoni Furoas 0.25 mg/g, Olopatadine 6 mg/g) | R01AD59 | CI |
|
|
